Trials / Conditions / Cardiac Dysfunction

Cardiac Dysfunction

11 registered clinical trials studyying Cardiac Dysfunction — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Comp NCT07110415	SPH Qingdao Growful Pharmacetical Co.,Ltd	Phase 4
Not Yet Recruiting	Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. NCT07157670	Assistance Publique - Hôpitaux de Paris	—
Active Not Recruiting	A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction NCT05806138	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Inju NCT05659589	Centre Hospitalier Universitaire, Amiens	N/A
Terminated	Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Impr NCT04433546	PhaseBio Pharmaceuticals Inc.	Phase 2
Completed	Football Players Health Study In Person Assessments Study NCT03866564	Massachusetts General Hospital	—
Recruiting	Cardiac Dysfunction in Childhood Cancer Survivors NCT03790943	University of Bern	—
Terminated	Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient NCT03085420	Shriners Hospitals for Children	N/A
Completed	Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remi NCT02581280	Yonsei University	—
Completed	MicroRNA Diagnostics in Subarachnoid Hemorrhage 2 NCT02320539	Rigshospitalet, Denmark	—
Unknown	Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block NCT02144766	Si-Qin Chen	Phase 4